These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs]. Müller RP, Peters PE. Strahlentherapie; 1985 Jan 07; 161(1):23-9. PubMed ID: 2982221 [Abstract] [Full Text] [Related]
6. [Results of lymphographic course controls following endolymphatic radionuclide therapy]. Wolf G. Med Welt; 1974 Jun 07; 25(23):1050-4. PubMed ID: 4410764 [No Abstract] [Full Text] [Related]
7. [Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system]. Richter G, Heidenbluth I, Heidelbach U. Dermatol Monatsschr; 1982 Dec 07; 168(12):797-806. PubMed ID: 7169101 [No Abstract] [Full Text] [Related]
8. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma]. Makoski HB, Magnus L, Heissen E, Kolpatzik H, Drepper H. Strahlentherapie; 1974 Jul 07; 148(1):1-15. PubMed ID: 4612879 [No Abstract] [Full Text] [Related]
9. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1]. Kokoschka E. Med Welt; 1974 Jun 07; 25(23):1054-5. PubMed ID: 4369551 [No Abstract] [Full Text] [Related]
10. [Therapy of endolymphatic metastastases in malignant melanoma using radioisotopes]. Weissleder H, Pfannenstiel P. Arch Dermatol Forsch; 1972 Jun 07; 244():245-50. PubMed ID: 4648699 [No Abstract] [Full Text] [Related]
14. Body distribution of intralymphatically injected radioactive colloid and oil. Erjavec M, Hacek S, Havlicek M, Klanjscek G. Radiobiol Radiother (Berl); 1969 Jun 07; 10(4):571-8. PubMed ID: 4312058 [No Abstract] [Full Text] [Related]
15. [Endolymphatic radionuclide therapy. Historical development and present status]. Makoski HB, Magnus L, Scherer E, Stauch GW, Strötges MW. Dtsch Med Wochenschr; 1973 Nov 16; 98(46):2207-13. PubMed ID: 4593334 [No Abstract] [Full Text] [Related]